Integrating Services to Address the Syndemics of HIV, STIs, Substance Use Disorder, and Viral Hepatitis
Resource updated 03/23/2023
Resource updated 03/23/2023
Resource updated 09/19/2023
Resource updated 04/18/2024
Resource updated 03/11/2024
Resource updated 06/18/2024
Resource updated 09/19/2023
Resource updated 04/03/2024
Resource updated 04/03/2024
Resource updated 03/04/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Description of how a modified Directly Observed Therapy (mDOT) program increased uptake of DOPT and the priority populations that experienced the uptake.
Resource (Conference Presentation) updated 09/14/2023
The objective of this study is to assess key stakeholders, including patients, for readiness to adopt a new standard of care. Because many people with HIV in Alabama experience low literacy, low income, and are racial minorities, data suggests they will experience greater barriers to healthcare information technology, like PROs and Telehealth.
Resource (Conference Presentation) updated 09/14/2023
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
The role of nurses in identifying and addressing social determinants of health in order to enhance viral suppression among people with HIV.
Resource (Conference Presentation) updated 09/14/2023
This session will share findings from the 2021 National Ending the HIV Epidemic (EHE) TA Implementation Meeting. The meeting provided increased opportunities for alignment and showcased disruptively innovative components forecasting future needs and highlighting EHE TA/CBA providers.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Project to determine the feasibility of integrating primary care services into syringe exchange programs.
Resource (Conference Presentation) updated 09/14/2023
Joining forces to End the HIV epidemic, the Northeast/Caribbean AIDS Education and Training Center worked across our diverse region to increase access to HIV care and prevention through a community-driven approach. Regional partners throughout our Region II jurisdiction collaborated to strengthen HIV testing, PrEP, viral suppression, and structural competency.
Resource (Conference Presentation) updated 09/14/2023